trastuzumab deruxtecan in her2-low advanced breast cancer | nejm
Published 1 year ago • 6.9K plays • Length 2:12Download video MP4
Download video MP3
Similar videos
-
2:06
trastuzumab deruxtecan for breast cancer | nejm
-
11:25
podcast 293: her2-“low” breast cancer and its reponse to an antibody-drug conjugate
-
2:15
capivasertib in advanced breast cancer | nejm
-
2:25
reducing risk in residual breast cancer
-
2:00
ribociclib in early breast cancer | nejm
-
6:39
expert report on advances in the management of her2-negative and her2-low advanced breast cancer
-
5:40
trastuzumab deruxtecan doubles pfs in metastatic breast cancer with low her2 expression
-
4:01
trastuzumab deruxtecan: a promising agent for treating her2-low breast cancer?
-
8:49
trastuzumab cardiotoxicity in destiny-breast04 trial
-
7:39
asco 2022: trastuzumab deruxtecan vs. treatment of physician's choice in her2-low unresectable a...
-
2:06
antibody-drug conjugates for her2-low disease: 2023 ku breast cancer year in review
-
3:31
her2-low mbc patients report preserved qol with trastuzumab deruxtecan
-
4:15
debbrah: t-dxd in her2 or her2-low advanced breast cancer with cns involvement
-
0:58
enhertu therapy: a powerful new cancer treatment
-
2:15
pd-1 blockade in locally advanced rectal cancer | nejm
-
8:25
new breast cancer drug delivers unprecedented levels of survival, stopping tumor growth
-
1:13
dr. hamilton on the efficacy of trastuzumab deruxtecan in her2-low breast cancer
-
3:43
evolving role of trastuzumab deruxtecan in her2 /her2-low mbc
-
2:01
destiny-breast04: practice-changing results for her2-low breast cancer